Literature DB >> 12536200

Generation of an adenoviral vector containing an addition of a heterologous ligand to the serotype 3 fiber knob.

Taco G Uil1, Toshiro Seki, Igor Dmitriev, Elena Kashentseva, Joanne T Douglas, Marianne G Rots, Jaap M Middeldorp, David T Curiel.   

Abstract

As an initial assessment of the feasibility of employing the adenovirus serotype 3 (Ad3) fiber knob as a locale for introducing a tropism-modifying motif, we generated an adenoviral vector containing a six-histidine tag genetically fused to the carboxy-terminus of the Ad3 fiber knob. The heterologous tag proved to be accessible for binding in the context of the virion and, moreover, had rendered the modified vector capable of mediating gene transfer through an artificial, non-Ad3 receptor.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12536200     DOI: 10.1038/sj.cgt.7700543

Source DB:  PubMed          Journal:  Cancer Gene Ther        ISSN: 0929-1903            Impact factor:   5.987


  6 in total

1.  Tropism modification of adenovirus vectors by peptide ligand insertion into various positions of the adenovirus serotype 41 short-fiber knob domain.

Authors:  Andrea Hesse; Daniela Kosmides; Roland E Kontermann; Dirk M Nettelbeck
Journal:  J Virol       Date:  2006-12-27       Impact factor: 5.103

2.  Targeting of adenovirus serotype 5 pseudotyped with short fiber from serotype 41 to c-erbB2-positive cells using bispecific single-chain diabody.

Authors:  Elena A Kashentseva; Joanne T Douglas; Kurt R Zinn; David T Curiel; Igor P Dmitriev
Journal:  J Mol Biol       Date:  2009-03-13       Impact factor: 5.469

3.  A phase I clinical trial of Ad5/3-Δ24, a novel serotype-chimeric, infectivity-enhanced, conditionally-replicative adenovirus (CRAd), in patients with recurrent ovarian cancer.

Authors:  Kenneth H Kim; Igor P Dmitriev; Souheil Saddekni; Elena A Kashentseva; Raymond D Harris; Rosemarie Aurigemma; Sejong Bae; Karan P Singh; Gene P Siegal; David T Curiel; Ronald D Alvarez
Journal:  Gynecol Oncol       Date:  2013-06-10       Impact factor: 5.482

4.  Virotherapy using a novel chimeric oncolytic adenovirus prolongs survival in a human pancreatic cancer xenograft model.

Authors:  Quyen D Chu; Guang Sun; Matt Pope; Natalia Luraguiz; David T Curiel; Roger Kim; Benjamin D L Li; J Michael Mathis
Journal:  Surgery       Date:  2012-07-31       Impact factor: 3.982

5.  Mutation of the fiber shaft heparan sulphate binding site of a 5/3 chimeric adenovirus reduces liver tropism.

Authors:  Anniina Koski; Eerika Karli; Anja Kipar; Sophie Escutenaire; Anna Kanerva; Akseli Hemminki
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

Review 6.  Progress in Adenoviral Capsid-Display Vaccines.

Authors:  Marija Vujadinovic; Jort Vellinga
Journal:  Biomedicines       Date:  2018-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.